Results 91 to 100 of about 1,267 (159)

Therapeutic Potential of Tricyclic Pyridazinone-Based Molecules: An Overview. [PDF]

Int J Mol Sci
Asproni B, Pinna GA, Corona P, Coinu S, Piras S, Carta A, Murineddu G.   +6 more
europepmc   +1 more source

Efficacy of Integrase Strand Transfer Inhibitors and the Capsid Inhibitor Lenacapavir against HIV-2, and Exploring the Effect of Raltegravir on the Activity of SARS-CoV-2. [PDF]

Viruses
Kiarie IW, Hoffka G, Laporte M, Leyssen P, Neyts J, Tőzsér J, Mahdi M.   +6 more
europepmc   +1 more source

Quinolinonyl Derivatives as Dual Inhibitors of the HIV-1 Integrase Catalytic Site and Integrase-RNA interactions. [PDF]

ACS Med Chem Lett
Patacchini E, Madia VN, Albano A, Ruggieri G, Messore A, Ialongo D, Saccoliti F, Scipione L, Cosconati S, Koneru PC, Haney R, Kvaratskhelia M, Di Santo R, Costi R.   +13 more
europepmc   +1 more source

30 years of HIV therapy: Current and future antiviral drug targets. [PDF]

Virology
Nuwagaba J, Li JA, Ngo B, Sutton RE.
europepmc   +1 more source

The mechanism of H171T resistance reveals the importance of Nδ-protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase

, 2014
Slaughter, A, Jurado, KA, Deng, N, Feng, L, Kessl, JJ, Shkriabai, N, Larue, RC, Fadel, HJ, Patel, PA, Jena, N, Fuchs, JR, Poeschla, E, Levy, RM, Engelman, A, Kvaratskhelia, M   +14 more
openalex   +1 more source

A comprehensive application of FiveFold for conformation ensemble-based protein structure prediction. [PDF]

Sci Rep
Niazi SK, Yang J.
europepmc   +1 more source

Alternaria alternata (Fr) Keissl Crude Extract Inhibits HIV Subtypes and Integrase Drug-Resistant Strains at Different Stages of HIV Replication. [PDF]

Pharmaceuticals (Basel)
Naidu D, Oduro-Kwateng E, Soliman MES, Ndlovu SI, Mkhwanazi NP.   +4 more
europepmc   +1 more source

Structural Virology: The Key Determinants in Development of Antiviral Therapeutics. [PDF]

Viruses
Handa T, Saha A, Narayanan A, Ronzier E, Kumar P, Singla J, Tomar S.   +6 more
europepmc   +1 more source

Inhibition of HIV-1 replication by primer RNA packaging inhibitors. [PDF]

mBio
Mirande M, Subra F, Richetta C, Deprez E, Delelis O.   +4 more
europepmc   +1 more source

State of the ART (antiretroviral therapy): Long-acting HIV-1 therapeutics. [PDF]

Glob Health Med
M Ravichandran S, M McFadden W, A Snyder A, G Sarafianos S.   +3 more
europepmc   +1 more source